Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2000 Jun;59(6):478–482. doi: 10.1136/ard.59.6.478

A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature

S F Sorensen 1, O Slot 1, N Tvede 1, J Petersen 1
PMCID: PMC1753166  PMID: 10834866

Abstract

OBJECTIVE—To test the usefulness of the Chapel Hill nomenclature, supplemented with surrogate parameters, as diagnostic criteria for primary vasculitides.
METHODS—To prospectively evaluate vasculitis patients according to a standardised clinical and para-clinical programme. In accordance with the Chapel Hill publication surrogate parameters were used: proteinuria, haematuria and red blood cell casts (glomerulonephritis), angiographic or ultrasonic demonstration of aneurysms or stenoses (arteritis), radiological lung infiltrates or cavitations of more than one month's duration (granuloma in the lungs), bloody nasal discharge or crusts, chronic sinusitis, otitis and/or mastoiditis, bone and/or cartilage destruction, and acute hearing loss (granuloma in upper airways).
RESULTS—The following entities were diagnosed: giant cell arteritis (n=14), Takayasu arteritis (n=1), polyarteritis nodosa (n=2), Wegener's granulomatosis (n=27), Churg-Strauss syndrome (n=2), microscopic polyangiitis (n=12), Henoch-Schönlein purpura (n=2), cutaneous leucocytoclastic angiitis (n=37), and secondary vasculitis (n=21). Giant cell arteritis and cutaneous leucocytoclastic angiitis were in all cases diagnosed by biopsy. Using the Chapel Hill nomenclature supplemented with surrogate parameters, only 8 of 27 patients were diagnosed with Wegener's granulomatosis, and 3 of 12 cases with microscopic polyangiitis. The number of patients in the remaining diagnostic entities were considered to few to evaluate.
CONCLUSIONS—The Chapel Hill nomenclature, supplemented with surrogate parameters, failed to act as diagnostic criteria in Wegener's granulomatosis and microscopic polyangiitis. The following diagnostic criteria are proposed for Wegener's granulomatosis: (1) Biopsy or surrogate parameter for granulomatous inflammation in the respiratory system and (2) Biopsy verified necrotising vasculitis in small to medium sized vessels or biopsy/surrogate parameter for glomerulonephritis or positive PR3-ANCA test and (3) Lack of eosinophilia in blood and biopsy samples. The following diagnostic criteria are proposed for microscopic polyangiitis: (1) Biopsy verified necrotising vasculitis in small vessels and/or glomerulonephritis with few or no immune deposits and (2) Involvement of more than one organ system as indicated by biopsy verified vasculitis in small to medium sized vessels or surrogate parameter for glomerulonephritis and (3) Lack of biopsy and surrogate parameter for granulomatous inflammation in the respiratory system. Using these criteria all Wegener's patients and 9 of 12 patients with microscopic polyangiitis could be diagnosed.



Full Text

The Full Text of this article is available as a PDF (111.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bengtsson B. A., Malmvall B. E. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. Arthritis Rheum. 1981 Jul;24(7):899–904. doi: 10.1002/art.1780240706. [DOI] [PubMed] [Google Scholar]
  2. Blanco R., Martínez-Taboada V. M., Rodríguez-Valverde V., García-Fuentes M. Cutaneous vasculitis in children and adults. Associated diseases and etiologic factors in 303 patients. Medicine (Baltimore) 1998 Nov;77(6):403–418. doi: 10.1097/00005792-199811000-00007. [DOI] [PubMed] [Google Scholar]
  3. Brimnes J., Nielsen O. H., Wiik A., Heegaard N. H. Autoantibodies to molecular targets in neutrophils in patients with ulcerative colitis. Dig Dis Sci. 1999 Feb;44(2):415–423. doi: 10.1023/a:1026683224057. [DOI] [PubMed] [Google Scholar]
  4. Exley A. R., Bacon P. A., Luqmani R. A., Kitas G. D., Gordon C., Savage C. O., Adu D. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum. 1997 Feb;40(2):371–380. doi: 10.1002/art.1780400222. [DOI] [PubMed] [Google Scholar]
  5. Jennette J. C., Falk R. J., Andrassy K., Bacon P. A., Churg J., Gross W. L., Hagen E. C., Hoffman G. S., Hunder G. G., Kallenberg C. G. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994 Feb;37(2):187–192. doi: 10.1002/art.1780370206. [DOI] [PubMed] [Google Scholar]
  6. Jennette J. C., Falk R. J. Small-vessel vasculitis. N Engl J Med. 1997 Nov 20;337(21):1512–1523. doi: 10.1056/NEJM199711203372106. [DOI] [PubMed] [Google Scholar]
  7. Lie J. T. Nomenclature and classification of vasculitis: plus ça change, plus c'est la même chose. Arthritis Rheum. 1994 Feb;37(2):181–186. doi: 10.1002/art.1780370205. [DOI] [PubMed] [Google Scholar]
  8. Luqmani R. A., Bacon P. A., Moots R. J., Janssen B. A., Pall A., Emery P., Savage C., Adu D. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994 Nov;87(11):671–678. [PubMed] [Google Scholar]
  9. Rao J. K., Allen N. B., Pincus T. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med. 1998 Sep 1;129(5):345–352. doi: 10.7326/0003-4819-129-5-199809010-00001. [DOI] [PubMed] [Google Scholar]
  10. Reid A. J., Harrison B. D., Watts R. A., Watkin S. W., McCann B. G., Scott D. G. Churg-Strauss syndrome in a district hospital. QJM. 1998 Mar;91(3):219–229. doi: 10.1093/qjmed/91.3.219. [DOI] [PubMed] [Google Scholar]
  11. Scott D. G., Watts R. A. Classification and epidemiology of systemic vasculitis. Br J Rheumatol. 1994 Oct;33(10):897–899. doi: 10.1093/rheumatology/33.10.897. [DOI] [PubMed] [Google Scholar]
  12. Watts R. A., Carruthers D. M., Scott D. G. Epidemiology of systemic vasculitis: changing incidence or definition? Semin Arthritis Rheum. 1995 Aug;25(1):28–34. doi: 10.1016/s0049-0172(95)80015-8. [DOI] [PubMed] [Google Scholar]
  13. Watts R. A., Jolliffe V. A., Carruthers D. M., Lockwood M., Scott D. G. Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis. Arthritis Rheum. 1996 Jul;39(7):1208–1212. doi: 10.1002/art.1780390720. [DOI] [PubMed] [Google Scholar]
  14. Watts R. A., Jolliffe V. A., Grattan C. E., Elliott J., Lockwood M., Scott D. G. Cutaneous vasculitis in a defined population--clinical and epidemiological associations. J Rheumatol. 1998 May;25(5):920–924. [PubMed] [Google Scholar]
  15. ZEEK P. M. Periarteritis nodosa; a critical review. Am J Clin Pathol. 1952 Aug;22(8):777–790. doi: 10.1093/ajcp/22.8.777. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES